Originally developed for managing Type 2 diabetes, it has also been shown to aid in weight loss by helping individuals feel fuller for longer and reducing cravings
The heterogeneity among individual studies was estimated by the Cochran Q test and quantified by I2 statistic
Furthermore, in a meta-analysis study, a moderate increase in the relative risk and a slight increase in absolute risk of thyroid cancer with the use of GLP-1 agonists was reported 48
I figured this bit of history, if I didnt tell it, would be lost. Table of contents How a small startup formed to study metabolic diseases In 1982, an endocrinologist from UCSF named John Baxter founded a company
I was looking for reliefand I wanted to support my body, not override it
At TrimRx, we bridge that gap by providing a telehealth-first platform where you have access to a dedicated team